Ribavirin and PEG interferon (IFN)- is successful in HCV-related mantle-cell lymphoma

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1415, 2003-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recurrent hepatitis C virus (HCV) infection after liver transplantation "can be safely treated" with PEG interferon (IFN)- -2b and ribavirin

By  

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

PEG IFN- -2b + ribavirin superior for HCV + HIV infection

By  

Inpharma, Vol. 1, Iss. 1469, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

PEG IFN- -2a/ribavirin superior to IFN- -2a/ribavirin in HCV + HIV

By  

Inpharma, Vol. 1, Iss. 1449, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

PEG IFN- -2b + ribavirin: 24 weeks sufficient for HCV-2 and HCV-3?

By  

Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

PEG IFN- -2a/ribavirin a good pick for HCV in HIV/HCV coinfection

By  

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite